Rationale for evaluating North America's first medically supervised safer-injecting facility
- 1 May 2004
- journal article
- review article
- Published by Elsevier in The Lancet Infectious Diseases
- Vol. 4 (5) , 301-306
- https://doi.org/10.1016/s1473-3099(04)01006-0
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Prevalence and Correlates of Untreated Human Immunodeficiency Virus Type 1 Infection among Persons Who Have Died in the Era of Modern Antiretroviral TherapyThe Journal of Infectious Diseases, 2003
- The Potential Public Health and Community Impacts of Safer Injecting Facilities: Evidence From a Cohort of Injection Drug UsersJAIDS Journal of Acquired Immune Deficiency Syndromes, 2003
- Safer Injection Facilities in North America: Their Place in Public Policy and Health InitiativesJournal of Drug Issues, 2002
- Impact of HIV Infection on Mortality in a Cohort of Injection Drug UsersJAIDS Journal of Acquired Immune Deficiency Syndromes, 2001
- Sex Differences in Risk Factors for HIV Seroconversion Among Injection Drug UsersArchives of internal medicine (1960), 2001
- Fatal Overdose Trends in Major us Cities: 1990–1997Addiction Research & Theory, 2001
- Drug consumption facilities in Europe and the establishment of supervised injecting centres in AustraliaDrug and Alcohol Review, 2000
- The social determinants of emergency department and hospital use by injection drug users in CanadaJournal of Urban Health, 1999
- Establishing safe injecting rooms in Australia: attitudes of injecting drug usersAustralian and New Zealand Journal of Public Health, 1999
- The professional acceptance of drug use: a closer look at drug consumption rooms in the Netherlands, Germany and SwitzerlandInternational Journal of Drug Policy, 1999